Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Antibodies are widely exploited as research/diagnostic tools and therapeutics. Despite providing exciting research opportunities, the multitude of available antibodies also offers a bewildering array of choice. Importantly, not all companies comply with the highest standards, and thus many reagents fail basic validation tests. The responsibility for antibodies being fit for purpose rests, surprisingly, with their user. This paper condenses the extensive experience of the European Monoclonal Antibody Network to help researchers identify antibodies specific for their target antigen. A stepwise strategy is provided for prioritising antibodies and making informed decisions regarding further essential validation requirements. Web-based antibody validation guides provide practical approaches for testing antibody activity and specificity. We aim to enable researchers with little or no prior experience of antibody characterization to understand how to determine the suitability of their antibody for its intended purpose, enabling both time and cost effective generation of high quality antibody-based data fit for publication.

Original publication

DOI

10.1080/19420862.2015.1100787

Type

Journal article

Journal

MAbs

Publication Date

2016

Volume

8

Pages

27 - 36

Keywords

BLAST searches, CiteAb, EuroMAbNet, HLDA workshops, flow cytometry, gene silencing, immunohistochemistry, monoclonal antibodies, validation studies, western blotting, Animals, Antibodies, Monoclonal, Biomedical Research, Databases, Factual, Europe, Humans